Regulation and Products

We are working to ensure the law granting the U.S. Food and Drug Administration (FDA) the authority to regulate all tobacco products, including cigarettes, e-cigarettes, cigars and hookah is fully leveraged to protect children and adults.  

Regulation and Products Resources:

Cigars pose a real danger to the long-term health of all Americans – and to young people especially – yet government regulation of cigars lags behind that of cigarettes and e-cigarettes. 

This factsheet provides a summary of the modified risk tobacco producat application process at FDA and ACS CAN's position.

American Cancer Society Cancer Action Network, American Academy of Pediatrics, American Heart Association, American Lung Association, Campaign for Tobacco-Free Kids, and Truth Initiative present the following principles FDA should use when implementing the premarket review process for tobacco products.

This factsheet provides a summary of the premarket review requirements and status of FDA's enforcement of the requirements.

A comment letter which details why 22nd Century Group's modified risk tobacco product application should be denied by the Food and Drug Administration.

Flavors are a marketing weapon the tobacco manufacturers use to target youth and young people to a lifetime of addiction. The use of any flavored tobacco product among youth is concerning because it exposes them to a lifetime of nicotine addiction, disease, and premature death.

The U.S. Secretary of HHS, U.S. Surgeon General, and Commissioner of the FDA have all declared youth e-cigarette use to be an epidemic. E-cigarette use among high school students has risen by 78 percent in the last year and 48 percent among middle school students. Furthermore, e-cigarette use is most common among younger adults – not older adults. Action is needed to reverse these trends.

Our organizations are writing in connection with the April 30 action by the U.S. Food and Drug Administration (FDA) issuing a marketing order to Philip Morris International (PMI) and Philip Morris Products S.A. allowing the U.S. marketing of IQOS heated tobacco products, to be distributed in the U.S. exclusively by Altria Client Services LLC (Altria).

The undersigned public health organizations submit these comments on the above-listed tobacco product modified risk applications submitted by R.J. Reynolds Tobacco Company (“Reynolds”) for six Camel snus products. The subject applications should be denied for the reasons detailed in these comments.